← Evidence map

ArticleCancer diagnosis & prognosis

FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel as First Line Treatment in Pancreatic Cancer: A Real-World Comparison.

Elena Orlandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 38434919